Logo Comprehensive Cancer Center Niedersachsen
Comprehensive Cancer Center Niedersachsen / CCC-N > About us > Principal Investigators > Dobbelstein

Prof. Dr. Matthias Dobbelstein

Matthias Dobbelstein is a Principal Investigator in SP5 and a member of the Curriculum Committee.
 

His research focuses on the tumor suppressor p53, its regulator MDM2, and the cellular response to DNA damage - key processes in cancer development. By targeting signaling cascades and nucleic acid synthesis, his work aims to improve cancer therapies and explore novel strategies against virus-infected cells.

Prof. Dobbelstein established the PhD Program of Molecular Medicine in 2010 and held its chair from 2010-2015. He has been the spokesperson for the EKFS-funded Promotionskolleg Genome Dynamic and Epigenomics and of the DFG College for Clinician Scientists Cell Dynamics in Disease and Therapy since 2017 and an associated member of the Max Planck Institute of Biophysical Chemistry since 2020.

Curriculum Vitae

Year Position
Since 2005 Director, Institute of Molecular Oncology, UMG
2004-2005 Professor of Molecular Oncology, Medical Biotechnology Center, University of Southern Denmark, Odense, Denmark
1999 Postdoctoral Award for Virus Research, Robert Koch Foundation
1998 Research Award, Hessian Cancer Society
1997-2004 Group Leader, Institute of Virology, Philipps University Marburg
1994 Dr. med. (“summa cum laude”), University of Munich, LMU (Supervisor: Prof. Dr. Ellen Fanning)
1993-1996 Postdoctoral Fellow with Prof. Dr. T. Shenk, Virology, Department of Molecular Biology, Princeton University, NJ (USA)
1993-1996 Scholarship Infectious Biology (AIDS scholarship), German Cancer Research Center Heidelberg
1986-1992 Scholarship for Highly Gifted Students from the State of Bavaria
1986-1992 Scholarship from the German Academic Scholarship Foundation
1986-1992 Studies of Human Medicine, University of Munich, LMU